CTRI/2024/05/067118
Not yet recruiting
Phase 3
A molecular genetic associationstudy of Male Infertility in PostCovid-19 patients and to study theeffect of Atmagupta (Mucuna pruriens) beeja churna – A randomized clinical trial ? - nil
Faculty of Ayurveda Institute of Medical Sciences BH0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: N469- Male infertility, unspecified
- Sponsor
- Faculty of Ayurveda Institute of Medical Sciences BH
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male patients aged 21 to 45 years Oligozoospermia (reduced sperm count) Multiple morphological abnormalities of sperm flagellum (MMAF) Previously diagnosed with COVID\-19 infection along with male InfertilityKnown case of male Infertility without prior Covid 19 infection
Exclusion Criteria
- •Females Patients with evidence of malignancy Known patients of the mechanical physical cause of Infertility like antisperm antibodies condition Obstruction Surgical process etc Known cases of HIV AIDS Hepatitis Tuberculosis etc. Noncooperative Patients Previous surgery of the male reproductive tract Cryptorchidism Uses of exogenous testosterone Patients who have an addiction of alcohol smoking Patients who have completed participation in any other clinical trial during the past six (06\) months Any other condition that the Principal Investigator thinks may jeopardize the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A research that investigates the genetic factors for the idiopathic pulmonary pneumonias (IIPs) with the subjects that have been enrolled in the multi-institutional observational study for the IIPs, NEJ030.Idiopathic pulmonary pneumoniaJPRN-UMIN000032117Jichi Medical University400
Recruiting
Not Applicable
The study of investigating the genetic profiles of Exceptional Response in cancer therapies.Cancer patient who received therapies.JPRN-UMIN000016643ational Cancer Center Hospital30
Completed
Phase 3
Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of strokeIschemic strokeJPRN-UMIN000008055Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences1,000
Completed
Not Applicable
Occupation affecting male infertility.Health Condition 1: null- Male factor infertilityCTRI/2018/11/016465ESI PGIMSR120
Completed
Not Applicable
Genetic study to identify genetic variants which affect clinical severity in Thai patients with beta thalassemia hemoglobin Eclinical variation in patients with beta thalassemia Hb E diseasebeta thalassemia Hb E disease, Thailand, genetic modifierTCTR20211022001Siriraj Hospital338